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Editorial on the Research Topic
Autophagy: From Big Data to Physiological Significance
Autophagy is a fundamental catabolic process where cytoplasmic components are sequestered
into double-membrane vesicles called autophagosomes, which then fuse with lysosomes and their
content is degraded. Our knowledge about autophagy sharply increased during the last decade. This
significant progress helped us to understand better the molecular mechanisms of autophagy and to
elucidate its role in health and disease. This special issue contains a collection of three original
research papers and 12 review articles covering a broad range of topics highlighting how big data
and screening approaches can help toward uncovering the molecular mechanisms of autophagy.
Recent years have witnessed the development of large-scale multi-omics studies on autophagy
via genomics, transcriptomics, proteomics, lipidomics, and metabolomics. Jacomin et al.
comprehensively describe the omics studies undertaken in the field of autophagy, and the
integration of these omics datasets for better understanding of autophagy regulation and the
involvement of autophagy in other biological processes. In addition, future approaches involving
single-cell analysis, patient-derived samples, and high-content analysis have been suggested. The
authors also outlined the web-based resources for studying autophagy, such as for the prediction of
Atg8-family interacting proteins, and autophagy network and databases. Overall, the emerging big
data and in silico tools not only elucidate the global landscape of autophagy but also provide critical
resources for further research in this field.
There is a growing interest toward the biomedical exploitation of autophagy modulators for
the treatment of myriad human diseases. Two articles comprehensively review the screening
methods for the drug discovery of chemical autophagy modulators. The first article by Panda et al.
summarizes the in vitro chemical screening approaches for identifying autophagy modulators in
mammalian cells. These methods that are commonly being used, involve reporters based on the
autophagic marker LC3 or specific autophagy substrates like p62 and certain aggregation-prone
proteins. The chemical screenings pertaining to the discovery of the pharmacological modulators
of autophagy have been described. Of biomedical relevance, the therapeutic benefits of autophagy
modulators have been highlighted in animal and iPSC models of selected human diseases, such
as in neurodegenerative disorders, cancer, infectious diseases, liver diseases, and myopathies, as
well as in lifespan extension. The second article by Mishra et al. primarily focuses on the chemical
biology strategies utilizing high-throughput assays to monitor autophagy in yeast and mammalian
cells. These assays are based on the growth of yeast cells, fluorescence readouts of LC3 reporters
in mammalian cells, and luminescence measurements of autophagic cargo clearance including
organelle turnover in both yeast and mammalian cells. Apart from describing the therapeutic
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applications of autophagy modulators, how these compounds act
as valuable tools to elucidate the regulation of autophagy have
also been highlighted.
For developing novel autophagy modulators, high-
throughput screens were undertaken in the research article
by Pengo et al. for identifying the regulators of ATG4B activity.
The protease ATG4B is a key regulator of the LC3/GABARAP
conjugation system essential for autophagosome formation.
Inhibition of ATG4B activity has been suggested for cancer
treatment. Through chemical and genetic screens utilizing a
cellular luciferase-based assay for measuring ATG4B activity,
the compound STK683963 and the kinase AKT2 were identified
as activators. Although this study focused on the enhancers of
ATG4B activity, these regulators could impact on the kinetics
of LC3/GABARAP processing and influence autophagy. The
datasets of ATG4B modulators arising from the screens have
been provided for further investigation.
There is significant development in the understanding of
the molecular mechanisms of autophagy regulation, such as
the initial steps of autophagosome biogenesis in mammals. The
review article by Grasso et al. provides a detailed overview
of the early events in mammalian autophagosome formation
including their membrane origins and cellular localization. The
four major aspects outlined in this article encompass autophagy
induction via physiological stressors, autophagy initiation via
mTOR and AMPK, initiation of autophagosome formation
via the ULK1 complex, and the molecular mechanisms of
phagophore generation prior to autophagosome formation.
Although it was initially believed to be a bulk process, it
is now well-established that autophagy is a selective process.
Xenophagy is a type of selective autophagy and refers to
the selective autophagic degradation of invading bacteria and
viruses, and is an important aspect of the hosts’ innate immune
response to protect against infection. Three review articles in
this collection highlight the importance of xenophagy in diseases.
Depending on the virus, autophagy can restrict or promote viral
replication, and play key roles in modulating inflammation and
cell survival. Ahmad et al. provide an overview of autophagy-
virus interplay highlighting the protective role of autophagy in
human infections. They summarize recent discoveries showing
the role of autophagy in immunity and inflammation upon
viral infection. Finally, they discuss therapeutic implications and
potential caveats associated with using autophagy to control
viral infections in humans. Sharma et al., focus on bacterial
degradation by autophagy. They describe how several bacterial
effectors regulate host autophagy during infection and how this
affects inflammation. They also present a detailed overview on
the role of several selective autophagy receptors and adaptors
on bacterial xenophagy. Finally, they describe how ubiquitin
ligases and deubiquitinases regulate bacterial xenophagy. Evans
et al., provide a comprehensive overview of the interplay between
host autophagy and eukaryotic pathogens. They focus on
eukaryotic pathogens Plasmodium, Toxoplasma, Leishmania, and
the fungal pathogens Candida albicans, Aspergillus fumigatus,
and Cryptococcus neoformans.
Neutrophils are effector cells of immune system in humans
and are the first cells to respond to tissue inflammation.
Skendros et al. review the role of autophagy in the biology
of neutrophils. They describe the link between autophagy
and regulation of granulopoiesis and neutrophil degranulation.
They also describe how autophagy affects net formation, the
extracellular chromatin strands carrying various highly active
neutrophil-derived granular and cytosolic proteins. Finally, they
explore how elements of autophagic machinery could be effective
therapeutic targets for the enhancement of antimicrobial defense
or the amelioration of neutrophil/NET-driven inflammation
and thrombosis.
Ianniciello et al. explore the relationship between autophagy
and metabolism in the leukemic stem cells (LSCs). They give
an overview of the metabolic features involved in hematopoietic
stem cells (HSCs) that utilize glycolysis and fatty acid oxidation
as sources of energy. HSCs develop high levels of autophagy;
ATG7, ATG5, and the ULK1 complex have been linked with
mitophagy in HSCs. Autophagy, which contributes to fuel
LSCs energy demand and hypoxic environment, along with
mutations and epigeneticsmodifications driving LSCs expansion,
are proposed to be principal contributors in HSCs leukemic
transformation. In conclusion, authors highlight the relevance
of combining current treatment with the autophagy inhibitor
chloroquine in LSCs.
Di Malta et al. focus in the transcriptional regulation
of autophagy, particularly on the role of the MiT/TFEB
transcription factor family. TFEB activation not only promotes
the increment of lysosomal catabolic efficiency but also controls
the expression of ATG genes driving the autophagic flux. The
description of the opposed role of ZKSCAN3 and TFEB let us
understand the nuclear events that control autophagy. Cytosolic
TFEB and nuclear ZKSCAN3 inhibit lysosome gene expression
under nutrient starvation conditions. Normoxia and hypoxia
conditions also regulate ATG genes such as Bnip3 through
NFKB and E2F1. Finally, they propose that the modulation of
the transcriptional control of autophagy could be considered as
possible therapeutic strategies for complex diseases.
Kocaturk and Gozuacik describe the relationship between
autophagy and ubiquitin proteasome system (UPS). Both
degradative mechanisms are linked by the ubiquitin signaling
pathway. Proteins with K48-based ubiquitin chains are
directed for UPS and aggregates with K63-based ubiquitin
chains are directed for autophagic degradation. Both K48-
and K63-linked ubiquitylation were observed in cases of
xenophagy, which is an example of coregulation of the
UPS and autophagy. In addition, UPS and autophagy act
as cooperative mechanisms in mitophagy, peroxiphagy,
and ERphagy. Moreover, UPS can regulate degradation of
transcription factors involved in autophagy. Eventually,
this article discusses the possible role of the cross talking
between autophagy and UPS in degenerative diseases
and cancer.
Daskalaki et al. present a comprehensive summary of recent
findings on selective autophagy in hypoxia and discuss emerging
links between these pathways and cancer pathophysiology. In
response to hypoxia, HIF-1 is stabilized and translocate to the
nucleus to initiate the transcription of multiple genes involved
in autophagy, glucose metabolism and mitochondria respiration.
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Importantly, HIF-1 regulates essential genes for the assembly and
function of the autophagy machinery. This article also focuses in
the role of FUN14 domain-containing protein 1(FUNDC1) in the
regulation of mitophagy in normoxia vs. hypoxia. Furthermore,
hypoxia induces degradation of other organelles by selective
autophagy and the components of these selective pathways in
cancer are discussed.
In the research article by, Pérez et al. a role of lysosome-
associated membrane protein LAMP-2C in the regulation
of melanoma growth and survival is presented. They
show that melanoma cell expression of LAMP2C mRNA
significantly increased in response to pro-inflammatory
cytokine interferon-gamma. This increased expression
affected macroautophagy and chaperone-mediated autophagy
in several human melanoma lines. Melanoma cells with
enhanced LAMP-2C expression displayed increased cell cycle
arrest, increased expression of Chk1 and p21, and greater
apoptosis and necrosis. In addition, human melanoma
cell xenografts with increased LAMP-2C expression,
displayed reduced growth in immune compromised
murine hosts. Melanomas with high LAMP-2C expression
showed increased necrosis and reduced cell density upon
histological analysis.
Nilangekar et al., developed new genetic tools to study
autophagy in the context of gametogenesis and germline stem
cell aging. They generated three transgenic lines mCherry-
Atg8a, GFP-Ref(2)P, and mito-roGFP2-Orp1 that are specifically
expressed in the germline compartment during Drosophila
oogenesis. These reporters can be used to monitor and quantify
autophagy and the production of reactive oxygen species during
oogenesis. They are a valuable tool that can be used in designing
genetic screens to identify novel regulators of autophagy and
redox homeostasis during oogenesis.
AUTHOR CONTRIBUTIONS
All authors listed have made a substantial, direct and
intellectual contribution to the work, and approved it
for publication.
FUNDING
This work was supported by Biotechnology and Biological
Sciences Research Council (grants BB/L006324/1 and
BB/P007856/1) and Leverhulme Trust Project Grant RPG-
2017-023 to IPN. SS has been funded by Wellcome Trust Seed
Award, UKIERI (UK-India Education and Research Initiative)
DST Thematic Partnership Award, LifeArc Philanthropic Fund,
FAPESP-Birmingham-Nottingham Strategic Collaboration
Fund, and Birmingham Fellowship from the University
of Birmingham.
ACKNOWLEDGMENTS
The authors would like to thank all the authors who contributed
to this Research Topic as well as the reviewers of the manuscripts
for their efforts.
Conflict of Interest: The authors declare that the research was conducted in the
absence of any commercial or financial relationships that could be construed as a
potential conflict of interest.
Copyright © 2020 Sarkar, Vaccaro and Nezis. This is an open-access article
distributed under the terms of the Creative Commons Attribution License (CC BY).
The use, distribution or reproduction in other forums is permitted, provided the
original author(s) and the copyright owner(s) are credited and that the original
publication in this journal is cited, in accordance with accepted academic practice.
No use, distribution or reproduction is permitted which does not comply with these
terms.
Frontiers in Cell and Developmental Biology | www.frontiersin.org 3 January 2020 | Volume 7 | Article 376
